Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 14 of 29

COMPLETED NA

Leveraging mHealth Messaging to Promote Adherence in Teens With CKD

NCT03651596

COMPLETED NA

A New Treatment for Mechanical Nasal Obstruction

NCT03456115

COMPLETED Phase 4

Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors

NCT03627299

COMPLETED NA

The Time-Restricted Intake of Meals Study

NCT03527368

COMPLETED NA

Pilot Study of the Liver Live Donor Champion Program

NCT03580629

COMPLETED

Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)

NCT04396041

TERMINATED NA

Interventions Made to Preserve Cognitive Function

NCT03616535

COMPLETED NA

Reducing Disability Following Hospital Discharge in Vulnerable Older Adults: The CAPABLE Intervention

NCT03456128

COMPLETED NA

Transnasal Therapy for Acute Migraine Attack

NCT04129567

COMPLETED Phase 1

Ketamine for Treatment of MS Fatigue

NCT03500289

COMPLETED NA

The Diet Gout Trial

NCT03569020

COMPLETED Phase 2

Trial of Roflumilast in Asthma Management (TRIM)

NCT03532490

COMPLETED

Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy

NCT03558204

COMPLETED Phase 2

Assessing the Safety of Buprenorphine in People With Sickle Cell Disease

NCT03492099

TERMINATED NA

Auricular Point Acupressure to Manage Pain in Patients With Alzheimer's Disease and Related Disorders

NCT03393546

TERMINATED NA

A Comparative Effectiveness Demonstration Project for Linkage and Retention in PrEP Care for Men Who Have Sex With Men

NCT03442192

COMPLETED NA

A Pilot Study of Remote Monitoring to Improve Health Related Quality of Life of Men Following Prostate Cancer Treatment.

NCT03434535

COMPLETED NA

Technology Based Community Health Nursing to Improve Combination Anti-Retroviral Therapy (cART) Adherence and Virologic Suppression in Youth Living With HIV

NCT03600103

COMPLETED NA

Building on Needle Exchange to Optimize Prevention & Treatment

NCT03567174

COMPLETED Phase 2

Acellular Adipose Tissue (AAT) for Soft Tissue Reconstruction

NCT03544632

COMPLETED Phase 1

A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis

NCT03423121

COMPLETED NA

Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy

NCT03526263

COMPLETED NA

Hemodynamics Response to Upper Airway Obstruction in Marfan Syndrome

NCT03985657

COMPLETED Phase 1

The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol

NCT03164512

COMPLETED Phase 2

Maternal Buprenorphine-naloxone Treatment and the Infant

NCT03291847

COMPLETED NA

Implementation of the Live Donor Champion Program

NCT03435510

COMPLETED Phase 1

Buspirone for Opioid Tapering

NCT03521960

COMPLETED Phase 1

Study of Pioglitazone in Sporadic Inclusion Body Myositis

NCT03440034

COMPLETED NA

A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial

NCT03350750

COMPLETED Phase 2

Evolocumab in Acute Coronary Syndrome

NCT03515304

COMPLETED NA

Effect of Late Dinner on Nocturnal Metabolism

NCT03525717

COMPLETED Phase 2

Effect of Evolocumab on Coronary Endothelial Function

NCT03500302

COMPLETED Phase 1

Differences in Cannabis Impairment and Its Measurement Due to Route of Administration

NCT03122691

TERMINATED

Ultra High Field MRI of Focal Pediatric Epilepsy

NCT03318237

TERMINATED NA

Effects of Repeated Memory Training on Memory Function and Addiction Related Processes

NCT03285256

COMPLETED Phase 2

Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study

NCT03345160

COMPLETED NA

Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms

NCT03035799

COMPLETED NA

HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

NCT03500315

COMPLETED NA

Baltimore HEARS: Hearing Health Equity Through Accessible Research & Solutions

NCT03442296

TERMINATED NA

EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses

NCT03485924

COMPLETED NA

The Role of Skin Care Regimen in Skin Health

NCT03497130

COMPLETED NA

Cultural Adaptation and Piloting of a Smoking Cessation Intervention for Smokers With HIV

NCT03580460

COMPLETED

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

NCT03441126

COMPLETED Phase 2

Baked Milk Oral Immunotherapy for Cow's Milk Allergy

NCT03462030

COMPLETED NA

Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease Patients

NCT02925065

COMPLETED NA

Behavioral Activation-Rehabilitation to Improve Depressive Symptoms & Physical Function After Acute Respiratory Failure

NCT03431493

COMPLETED NA

Five, Plus Nuts and Beans for Kidneys

NCT03299816

COMPLETED NA

Scrambler Trial for Pain in NMOSD

NCT03452176

TERMINATED NA

Auricular Point Acupressure: Examining the Scientific Underpinnings of Pain Relief

NCT03634527

COMPLETED Phase 2

Pilot of Zinc Acetate to Improve Chronic Cough

NCT03135522

← Previous Page 14 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.